Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other hematologic neoplasm 2Myeloid 2Sarcoma 1Plasma cell 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Leukemia, Myeloid, Acute 385Myelodysplastic Syndromes 153Leukemia, Myelomonocytic, Chronic 76Leukemia 65Recurrence 27Hematologic Neoplasms 20Myeloproliferative Disorders 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Anemia, Refractory, with Excess of Blasts 14Neoplasms 13Neoplasm, Residual 11Multiple Myeloma 11Leukemia, Monocytic, Acute 11Leukemia, Lymphocytic, Chronic, B-Cell 11Leukemia, Biphenotypic, Acute 11Lymphoma, Non-Hodgkin 10Leukemia, Myelomonocytic, Acute 10Primary Myelofibrosis 9Leukemia, Erythroblastic, Acute 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Myelodysplastic-Myeloproliferative Diseases 8Lymphoma 8Leukemia, Myeloid 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Megakaryoblastic, Acute 8Congenital Abnormalities 8Leukemia, Myelomonocytic, Juvenile 5Hodgkin Disease 5GATA2 Deficiency 5Lymphoma, Large B-Cell, Diffuse 4

Interventions

Nivolumab 2Counseling 2Bupropion 2Azacitidine 2venetoclax 1temsirolimus 1sargramostim 1pembrolizumab 1motexafin gadolinium 1mivebresib 1margetuximab 1entinostat 1cc-486 1Zinc Oxide 1Varenicline 1Tretinoin 1Topotecan 1Tobacco Use Cessation Devices 1Thalidomide 1TTI-621 1Specimen Handling 1Rituximab 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Paracentesis 1Nicotine Replacement Therapy 1Nicotine 1Monatide (IMS 3015) 1Metformin 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × Azacitidine × Other hematologic neoplasm × Clear all
NCT02712905 2025-11-04

An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

Incyte Corporation

Phase 1/2 Terminated
116 enrolled 36 charts
MyeloidOther hematologic neoplasmThoracic

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Primary Myelofibrosis, Small Cell Lung Carcinoma

NCT02223052 2020-05-12

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Celgene

Phase 1 Completed
89 enrolled
BreastCNSDermatologicGenitourinaryGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glioblastoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Skin Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡